List of Excipients in API NOREPINEPHRINE BITARTRATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing NOREPINEPHRINE BITARTRATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE | norepinephrine bitartrate | 0338-0112 | DEXTROSE MONOHYDRATE | |
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE | norepinephrine bitartrate | 0338-0112 | HYDROCHLORIC ACID | |
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE | norepinephrine bitartrate | 0338-0112 | SODIUM HYDROXIDE | |
| Hospira Inc | LEVOPHED | norepinephrine bitartrate | 0409-0161 | SODIUM CHLORIDE | |
| Hospira Inc | LEVOPHED | norepinephrine bitartrate | 0409-0161 | SODIUM METABISULFITE | |
| Hospira Inc | LEVOPHED | norepinephrine bitartrate | 0409-3375 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing NOREPINEPHRINE BITARTRATE
Detailed excipient profiles for NOREPINEPHRINE BITARTRATE
Excipient focus: DEXTROSE MONOHYDRATE
NOREPINEPHRINE BITARTRATE drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | norepinephrine bitartrate | 0338-0112 |
| >Company | >Ingredient | >NDC |
NOREPINEPHRINE BITARTRATE drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: EDETATE DISODIUM
NOREPINEPHRINE BITARTRATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | norepinephrine bitartrate | 70710-1785 |
| Zydus Lifesciences Limited | norepinephrine bitartrate | 70771-1724 |
| Long Grove Pharmaceuticals LLC | norepinephrine bitartrate | 81298-9659 |
| >Company | >Ingredient | >NDC |
NOREPINEPHRINE BITARTRATE drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
NOREPINEPHRINE BITARTRATE drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | norepinephrine bitartrate | 0338-0112 |
| WG Critical Care LLC | norepinephrine bitartrate | 44567-640 |
| Long Grove Pharmaceuticals LLC | norepinephrine bitartrate | 81298-9659 |
| >Company | >Ingredient | >NDC |
NOREPINEPHRINE BITARTRATE drug variants not containing HYDROCHLORIC ACID
Excipient focus: NITROGEN
NOREPINEPHRINE BITARTRATE drug variants containing NITROGEN
NOREPINEPHRINE BITARTRATE drug variants not containing NITROGEN
Excipient focus: SODIUM CHLORIDE
NOREPINEPHRINE BITARTRATE drug variants containing SODIUM CHLORIDE
NOREPINEPHRINE BITARTRATE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | norepinephrine bitartrate | 0338-0112 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
NOREPINEPHRINE BITARTRATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | norepinephrine bitartrate | 0338-0112 |
| WG Critical Care LLC | norepinephrine bitartrate | 44567-640 |
| Long Grove Pharmaceuticals LLC | norepinephrine bitartrate | 81298-9659 |
| >Company | >Ingredient | >NDC |
NOREPINEPHRINE BITARTRATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM METABISULFITE
NOREPINEPHRINE BITARTRATE drug variants containing SODIUM METABISULFITE
NOREPINEPHRINE BITARTRATE drug variants not containing SODIUM METABISULFITE
Excipient focus: WATER
NOREPINEPHRINE BITARTRATE drug variants containing WATER
NOREPINEPHRINE BITARTRATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
